Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imelda Marton

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Orvosi Hetilap|November 14, 2009
[Prognostic value of FDG-PET in Hodgkin lymphoma for posttreatment evaluation. Long-term follow-up results]Zsuzsa Molnár, Zsófia Simon, Zita Borbényi, et al.
Acta Haematologica|July 20, 2025
Practical Management of Cardiovascular Adverse Events with BTKi Treatment in Patients with Chronic Lymphocytic Leukemia: A Consensus Report by Hematologists and CardiologistsTalha Munir, Eglė Čiburienė, Vasko Graklanov, et al.
International Journal of Molecular Sciences|March 13, 2024
Clinical and Molecular Characterization of Nine Novel Antithrombin MutationsJudit Kállai, Réka Gindele, Krisztina Pénzes-Daku, et al.
Advances in Therapy|April 2, 2014
Peripheral blood stem cell mobilization and engraftment after autologous stem cell transplantation with biosimilar rhG-CSFPéter Reményi, László Gopcsa, Imelda Marton, et al.
Leukemia Research|January 7, 2018
Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasmsAmbrus Gángó, Réka Mózes, Zsófia Boha, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Orvosi Hetilap|November 14, 2009
[Prognostic value of FDG-PET in Hodgkin lymphoma for posttreatment evaluation. Long-term follow-up results]Zsuzsa Molnár, Zsófia Simon, Zita Borbényi, et al.
Acta Haematologica|July 20, 2025
Practical Management of Cardiovascular Adverse Events with BTKi Treatment in Patients with Chronic Lymphocytic Leukemia: A Consensus Report by Hematologists and CardiologistsTalha Munir, Eglė Čiburienė, Vasko Graklanov, et al.
International Journal of Molecular Sciences|March 13, 2024
Clinical and Molecular Characterization of Nine Novel Antithrombin MutationsJudit Kállai, Réka Gindele, Krisztina Pénzes-Daku, et al.
Advances in Therapy|April 2, 2014
Peripheral blood stem cell mobilization and engraftment after autologous stem cell transplantation with biosimilar rhG-CSFPéter Reményi, László Gopcsa, Imelda Marton, et al.
Leukemia Research|January 7, 2018
Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasmsAmbrus Gángó, Réka Mózes, Zsófia Boha, et al.
Pageof 3